US Patent Issued to Triad National Security, Oxford University Innovation, The Trustees of the University of Pennsylvania, Beth Israel Deaconess Medical Center on July 22 for "Conserved region T cell vaccines for coronavirus and methods of use" (American, British Inventors)

ALEXANDRIA, Va., July 23 -- United States Patent no. 12,364,750, issued on July 22, was assigned to Triad National Security LLC (Los Alamos, N.M.), Oxford University Innovation Ltd. (Oxford, Great Britain), The Trustees of the University of Pennsylvania (Philadelphia) and Beth Israel Deaconess Medical Center Inc. (Boston).

"Conserved region T cell vaccines for coronavirus and methods of use" was invented by Bette T. M. Korber (Los Alamos, N.M.), James Theiler (Los Alamos, N.M.), Dan Barouch (Boston), Drew Weissman (Philadelphia) and Tomas Hanke (Oxford, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "Immunogenic compositions and methods of their use in eliciting immune responses to coronaviruses...